Accounts Receivable, after Allowance for Credit Loss, Current of NEUROONE MEDICAL TECHNOLOGIES Corp from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Dec 2025 was $2,661,867, a 12% increase year-over-year.
Source SEC data
View on sec.gov
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $2,661,867 +$292,954 +12% 31 Dec 2025 10-Q 17 Feb 2026 2026 Q1
Q3 2025 $1,264,805 +$1,088,169 +616% 30 Sep 2025 10-Q 17 Feb 2026 2026 Q1
Q1 2025 $318,780 -$236,859 -43% 31 Mar 2025 10-Q 13 May 2025 2025 Q2
Q4 2024 $2,368,913 +$1,825,514 +336% 31 Dec 2024 10-Q 12 Feb 2025 2025 Q1
Q3 2024 $176,636 30 Sep 2024 10-K 17 Dec 2025 2025 FY
Q2 2024 $410,551 30 Jun 2024 10-Q 14 Aug 2024 2024 Q3
Q1 2024 $555,639 +$341,687 +160% 31 Mar 2024 10-Q 14 May 2024 2024 Q2
Q4 2023 $543,399 +$448,080 +470% 31 Dec 2023 10-Q 13 Feb 2024 2024 Q1
Q1 2023 $213,952 +$177,368 +485% 31 Mar 2023 10-Q 12 May 2023 2023 Q2
Q4 2022 $95,319 +$70,691 +287% 31 Dec 2022 10-Q 13 Feb 2023 2023 Q1
Q3 2022 $33,237 -$15,099 -31% 30 Sep 2022 10-K 15 Dec 2023 2023 FY
Q1 2022 $36,584 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $24,628 31 Dec 2021 10-Q 14 Feb 2022 2022 Q1
Q3 2021 $48,336 30 Sep 2021 10-K 22 Dec 2022 2022 FY
Q2 2021 $40,096 30 Jun 2021 10-Q 13 Aug 2021 2021 Q3
Q4 2015 $0 $0 31 Dec 2015 10-K 14 Apr 2016 2015 FY
Q4 2014 $0 31 Dec 2014 10-K 14 Apr 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.